Webinar "Public support for international expansion of pharmaceuticals and medical devices"
Organized by: Nagasaki University Institute of Tropical Medicine NTD Innovation Center / Japan Neglected Tropical Diseases Alliance
Date: May 21, 2021 (Friday) 15: 00-17: 00
Registration (free): https://zoom.us/webinar/register/WN_Rht69qGHTyGqz_kt9RSuFw
Abstract
Nagasaki University has been entrusted with the WHO pre-certification and recommendation acquisition of the Ministry of Health, Labor and Welfare in the first year of Reiwa and the second year of Reiwa, and the promotion project of listing the WHO recommended equipment handbook for developing countries, and international expansion of pharmaceuticals and medical devices related to global health. We have been collecting information, networking, and holding seminars to promote this. While implementing the business, there are many companies in Japan that have excellent technological seeds, but many of these companies are small and medium-sized enterprises, and the challenges of expanding overseas on their own have become apparent. Therefore, as one way to overcome this problem, we are currently focusing on public support, identifying and mapping available public support at each development stage, from grasping local needs to research and development and entering the international market. We are. In this webinar, we will share this achievement with you, provide information from major public institutions that provide public support for the international expansion of pharmaceuticals and medical devices, and introduce case studies from companies.
アジェンダ（敬称略）
| Public support for the international expansion of pharmaceuticals and medical devices | Nagasaki University Institute of Tropical Medicine NTD Innovation Center Director So Kaneko |
| Support for overseas expansion of the healthcare industry by the Ministry of Economy, Trade and Industry and JETRO | Yuriko Hideshima, International Development Promotion Office, Healthcare Industry Division, Commerce and Service Group, Ministry of Economy, Trade and Industry / JETRO Deputy Chief, Overseas Market Development Division, Market Development and Exhibition Division Tsutomu Fujimoto |
| About JICA's SME / SDGs business support project | Japan International Cooperation Agency (JICA) Private Partnership Division Corporate Collaboration Section 2 Kazuya Otsuka |
| About practical research projects such as medical technology in developing and emerging countries | Minoru Ishiguro, Medical Device Research and Development Division, Medical Device and Healthcare Division, Japan Agency for Medical Research and Development (AMED) |
| Examples of public-private partnerships in Africa | Sysmex Corporation Overseas Business Promotion Department International Cooperation Business Group |
| Protein production platform using silk moth-Development for responding to new coronavirus infectious diseases- | Masahiro Taniguchi, Development and Sales Manager, KAICO Co., Ltd. |
| Public discussion "To promote the international expansion of pharmaceuticals and medical devices" |
本ウェビナーは終了致しました。
ウェビナー「途上国の感染症対策に資する診断薬開発を推進するために」（第2弾）
Organized by: Nagasaki University Institute of Tropical Medicine NTD Innovation Center / Japan Neglected Tropical Diseases Alliance
Date and time: Friday, January 29, 2021 10: 00-11: 30 (JST)
Abstract
Malaria, tuberculosis, neglected tropical diseases. Behind the global epidemic of the new coronavirus, these traditional infectious diseases continue to threaten the lives and livelihoods of people in developing countries. It is said that one of the obstacles in advancing measures against these infectious diseases is the absence or lack of high-quality and easy-to-use diagnostic agents. Especially for neglected tropical diseases, the ability to develop the necessary diagnostics will determine the success or failure of the measures for the next 10 years. The Nagasaki University NTD Innovation Center holds a series of webins mainly for companies with the aim of promoting the development of diagnostic agents in Japan and their launch in the international market. In this second seminar, we will introduce development strategies and diagnostic drug technologies for infectious disease diagnostics targeting the international market, and what obstacles Japanese companies have in entering the international market and what companies are dealing with. We will set up a forum for discussing with participants whether they need such support.
アジェンダ（敬称略）
Development Strategy for New Diagnostic Methods Targeting the International Market / Foundation for Innovative New Diagnostics (FIND) Marta Fernandez
Possibility of application of immunochromatography method: Rabies / Adtech Co., Ltd. Yukiharu Kobayashi
STH-PAS as POCT, its basic technology and application: Dengue fever, corona, etc./TBA Co., Ltd. Mitsuo Kawase
High-sensitivity antibody sensor technology using bio-nanocapsule technology: Leishmania / Vehicle Co., Ltd. Yasumasa Go
Public discussion "Obstacles to entry into the international market and support from the Japanese government"
おわりに ／ JAGntd 吉岡浩太
The following webinar has ended. You can see the recording and presentation materials below.
"To promote the development of diagnostic agents that contribute to infectious disease control in developing countries" (1st)
Date and time: Friday, October 30th 10: 00-11: 30
Abstract
Malaria, tuberculosis, neglected tropical diseases. With the new coronavirus catching the eye of the world, these traditional infectious diseases continue to threaten the lives and livelihoods of people in developing countries. Currently, measures against malaria, tuberculosis and neglected tropical diseases are being promoted all over the world, but one of the obstacles to the measures is said to be the absence or lack of high-quality and easy-to-use diagnostic agents. Especially for neglected tropical diseases, the ability to develop the necessary diagnostics will determine the success or failure of the measures for the next 10 years. The Nagasaki University NTD Innovation Center has planned a webinar mainly for companies with the aim of encouraging Japanese stakeholders to participate in the development of diagnostic agents. This seminar will provide information on global trends in diagnostic drug development needs and approval processes, examples of diagnostic drug development by Japanese companies, and product development programs invested by the GHIT Fund (Global Health Innovative Technology Fund). To do.
Agenda and presentation materials (titles omitted)
Trends in Diagnostic Drug Approval Process by World Health Organization (WHO) / Nagasaki University NTDi Center Satoshi Kaneko
Tuberculosis Diagnostic Drug Development Needs / Stop Tuberculosis Partnership Shinichi Takenaka
Malaria Diagnostic Drug Development Needs / Malaria No More Japan Shigeyuki Kano
Neglected Tropical Disease Diagnostic Drug Development Needs / Japan Neglected Tropical Disease Alliance Kota Yoshioka
Examples of Diagnostic Drug Development for Developing Countries: Issues and Prospects / Eiken Chemical Co., Ltd. Yasuyoshi Moriyasu
Introduction of product development subsidy programs in developing countries including diagnostics / GHIT Fund Hayashi Urabe
- Webinar recording (partial excerpt)
